Brief: Neovacs Invests 4.2 Mln In COVID-19 Screening Company Bio Detection K9

Neovacs SA

27/09/2021 07:11

Sept 27 (Reuters) - Neovacs SA  ALNEV.PA :
    * MAKES ITS FIRST EQUITY INVESTMENT IN A COMPANY DEDICATED
TO
COVID-19 SCREENING
    * THE COMPANY ANNOUNCED A $5 MILLION (€4.2 MILLION)
INVESTMENT IN
BIO DETECTION K9, A CANADIAN COMPANY
    * BIO DETECTION K9 WILL BE 35% OWNED BY NEOVACS AND 65% BY
PRIORITY ONE CANINE (P1K9)

Source text for Eikon:  ID:nACT71177 
Further company coverage:  ALNEV.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))